Article ID Journal Published Year Pages File Type
5825716 Clinical Therapeutics 2013 12 Pages PDF
Abstract
After MI, early treatment with licensed n-3 fatty acids was associated with improvement in all-cause mortality in patients with and without type 2 diabetes, against a background of contemporary cardiovascular risk-modifying treatments.
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Authors
, , , , , , , ,